Xenetic

$2.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.46%) Today

-$0.05 (-2.30%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Xenetic and other stocks, options, and ETFs commission-free!

About XBIO

Xenetic Biosciences, Inc. Common Stock, also called Xenetic, is a biopharmaceutical company, which engages in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells.

CEO

Jeffrey F. Eisenberg

Employees

Headquarters

Framingham, Massachusetts

Founded

2011

Market Cap

18.37M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

182.57K

High Today

$2.18

Low Today

$2.11

Open Price

$2.18

Volume

35.06K

52 Week High

$5.85

52 Week Low

$0.73

XBIO Earnings

-$1.20

-$0.80

-$0.40

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 13, After Hours